[Anti-PR3 positive inflammatory bowel disease. Description of a case]

Caterina Defendenti1, Simona Bollani, Maria Francesca Spina

  • 1Laboratorio Analisi, Ospedale Fatebenefratelli, Milano. caterina.defendenti@fbf.milano.it

Insights

This case study highlights a patient with inflammatory bowel disease experiencing erythema nodosum and anti-neutrophil cytoplasmic antibody-associated vasculitis (ANCA). Bacterial infections, including Salmonella and Staphylococcus aureus, were noted, and treatment with antibiotics and steroids proved effective.

Area of Science:

  • Gastroenterology
  • Rheumatology
  • Infectious Diseases

Background:

  • Inflammatory bowel disease (IBD) encompasses chronic gastrointestinal inflammation.
  • Erythema nodosum is a common extraintestinal manifestation of IBD.
  • Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, particularly anti-PR3 positivity, can occur in IBD patients.

Observation:

  • A case of IBD is presented with concurrent erythema nodosum.
  • The patient exhibited positivity for anti-PR3 antibodies.
  • The patient had a history of salmonellosis and a current Staphylococcus aureus infection.

Findings:

  • The co-occurrence of IBD, erythema nodosum, and anti-PR3 positivity suggests a complex interplay of immune dysregulation.
  • Bacterial infections may act as potential triggers or complicating factors in this clinical scenario.
  • Treatment with antibiotics and corticosteroids demonstrated efficacy in managing the patient's condition.

Implications:

  • This case underscores the importance of considering ANCA-associated vasculitis in IBD patients presenting with erythema nodosum.
  • Identifying and treating bacterial infections may be crucial for managing complex IBD cases.
  • The findings suggest a potential therapeutic role for antibiotics and steroids in such complicated presentations.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...